13 May 2026, Shanghai

We attended API China 2026 in Shanghai as industry visitors, to keep track of the latest developments in pharmaceutical raw materials, veterinary APIs, nutraceutical ingredients and pharmaceutical excipients sectors.

From this exhibition, we gained clear market insights. Buyers across global markets now prioritize stable supply capacity, complete regulatory documentation, and standardized quality management, instead of focusing merely on competitive pricing. For veterinary APIs, market demand is becoming more segmented, with higher requirements for registration compliance and cold-chain logistics control.

Nutraceutical raw materials continue to grow steadily, driven by rising global health awareness, while pharmaceutical excipients see stricter standards for compatibility, safety and batch consistency.

This visit enables us to grasp the latest industry trends, optimize our product layout and sourcing strategy. We will keep focusing on quality compliance and reliable supply, to deliver professional and cost-effective raw material solutions for global partners.